Recurrent or persistent thyroid cancer of follicular cell origin.
Most patients with differentiated thyroid cancer of follicular cell origin have a favorable postoperative course, and their prognosis often appears to be unrelated to the extent of initial surgical treatment in some studies. Important questions that need to be addressed include whether the extent of the initial operation has any impact on the subsequent tumor-free survival and total survival, and whether patients with persistent or recurrent disease benefit from reoperation.
Duren
M
M
Department of Surgery, University of California, San Francisco/Mount Zion Medical Center, San Francisco, CA 94143-1674, USA.
Duh
Q Y
QY
Siperstein
A E
AE
Clark
O H
OH
D018263:Adenocarcinoma, Follicular / Q000473:pathology / Q000601:surgery*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D013964:Thyroid Neoplasms / Q000473:pathology / Q000601:surgery*; D013965:Thyroidectomy; D016896:Treatment Outcome